Clinical Trials

3,228 enrolled 41 charts

Lung Neoplasms, Tobacco Use Disorder, Smoking Cessation

NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

546 enrolled 29 charts

Pancreatic Intraductal Neoplasms

NCT05731947 2026-01-29

Evaluation of Revumenib in Participants With Colorectal Cancer and Other Solid Tumors

Phase 1/2 Completed

42 enrolled

Colorectal Neoplasms

NCT03556904 2026-01-15

FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)

14 enrolled 16 charts

Genitourinary

Prostatic Neoplasms

NCT07304388 2025-12-30

HAIC Plus Systemic Chemotherapy, Lenvatinib and Toripalimab in Advanced ICC

96 enrolled

Cirrhosis, Familial, with Pulmonary Hypertension, Cholangiocarcinoma

NCT02314182 2025-12-19

GRECCAR8

5 enrolled

Rectal Neoplasms

NCT03676257 2025-12-10

Survival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life Databases

20,033 enrolled 9 charts

Breast Neoplasms

NCT04699539 2025-12-10

Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer

96 enrolled 12 charts

Treatment

NCT04943497 2025-12-09

PROSPERITY

2,424 enrolled

Breast Neoplasms

NCT05440916 2025-12-02

PRIMM

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02918955 2025-11-20

UPFRONT-NECK

65 enrolled

Head & Neck

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Oropharyngeal Neoplasms

NCT04603586 2025-10-20

Stereotactic Radiotherapy in Locally Advanced Pancreatic Cancer With Different Biological Effective Doses

119 enrolled 10 charts

Treatment

NCT03426891 2025-10-06

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

21 enrolled 12 charts

CNS

Brain Neoplasms, Glioblastoma

NCT05775796 2025-10-01

Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Resectable NSCLC (ECTOP-1013)

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341998 2025-09-19

SCRRYST

Phase 2/3 Completed

32 enrolled

Neoplasms, Germ Cell and Embryonal, Endodermal Sinus Tumor

NCT07152938 2025-09-15

AVR-CHEMO

BreastGastrointestinalLymphoidPlasma cell

150 enrolled

Agnosia, Anxiety Disorders, Breast Neoplasms, Colonic Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms

NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

289 enrolled 32 charts 1 FDA

Recurrence

NCT07127315 2025-08-17

Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy

100 enrolled

CNSDermatologicGastrointestinalGynecologicHead & NeckLymphoidThoracic

Breast Neoplasms

NCT02327078 2025-08-14

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Phase 1/2 Completed

307 enrolled 27 charts

Glioblastoma, Head and Neck Neoplasms, Lung Neoplasms, Lymphoma, Melanoma, Ovarian Neoplasms, Colorectal Neoplasms

NCT06186700 2025-07-28

Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer

100 enrolled

Other

Mucositis

NCT06048913 2025-07-04

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

56 enrolled

Esophageal Neoplasms

NCT04625803 2025-06-17

Neoadjuvant Therapy for Locally Advanced Colon Cancer

64 enrolled 11 charts

Colonic Neoplasms

NCT06533722 2025-06-10

Adaptive Therapy for Post-Second-Line Advanced Breast Cancer

10 enrolled

HER2-negative Metastatic Breast Cancer

NCT04082364 2025-06-08

MAHOGANY

Phase 2/3 Completed

82 enrolled 22 charts

Stomach Neoplasms

NCT06990347 2025-05-25

A Study on the Efficacy and Safety of IPyC for HER2+ MBC

301 enrolled

Breast Neoplasms

NCT06980792 2025-05-20

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

90 enrolled

GenitourinaryOther solid neoplasmThoracic

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02649829 2025-04-29

MESODEC

Phase 1/2 Completed

28 enrolled

Mesothelioma, Malignant, Wilms Tumor

NCT03632135 2025-04-15

CSCRGBM

78 enrolled 10 charts

CNS

Brain Neoplasms, Glioblastoma

NCT03257267 2025-04-08

Study of Cemiplimab in Adults With Cervical Cancer

608 enrolled 18 charts

Carcinoma, Squamous Cell, Neoplasm Metastasis, Recurrence

NCT03353831 2025-04-06

Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer

574 enrolled

Gynecologic

Ovarian Neoplasms

NCT03409614 2025-03-13

Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer

790 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT02278887 2025-03-10

TIL

168 enrolled

Dermatologic

Melanoma

NCT04997382 2025-02-25

CLASSIC5

112 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04091867 2025-02-24

sEphB4-HSA With RT+Chemo or Cetux in Patients With Intermediate to High Risk LAHNSCC

3 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT01957735 2025-02-19

BP31510 (Ubidecarenone,USP) Nanosuspension for Intravenous Injection to Patients With Solid Tumors

97 enrolled

CNSLymphoid

Brain Neoplasms, Lymphoma, Neoplasm Metastasis, Neoplasms

NCT02116530 2025-01-28

Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy

Other hematologic neoplasm

401 enrolled 14 charts

Nausea, Vomiting, Hematologic Neoplasms

NCT03314740 2025-01-10

BAROCCO

123 enrolled 14 charts

Gynecologic

Ovarian Neoplasms

NCT04449861 2024-11-27

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

166 enrolled 20 charts

Small Cell Lung Carcinoma Extensive Disease

NCT03248570 2024-11-20

Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects

26 enrolled 18 charts

Genitourinary

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT03227328 2024-11-07

KENDO

52 enrolled

Breast Neoplasms

NCT03985046 2024-11-07

Sintilimab Plus Chemotherapy Followed by dCRT in Locally Advanced ESCC

75 enrolled

Esophageal Squamous Cell Carcinoma

NCT03873883 2024-09-19

IO-001

119 enrolled

Tumor-Agnostic

Neoplasms

NCT02826486 2024-08-28

COMBAT

80 enrolled 13 charts

Metastatic Pancreatic Adenocarcinoma

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Phase 2/3 Completed

60 enrolled

Head & Neck

Mouth Neoplasms

NCT03539406 2024-08-09

INTRO

11 enrolled

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02668653 2024-08-06

QuANTUM-First

539 enrolled 20 charts 1 FDA

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

72,408 enrolled

Genitourinary

Kidney Neoplasms, Neoplasms, Second Primary

NCT04902885 2024-07-10

Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients

95 enrolled 27 charts

Small Cell Lung Carcinoma

NCT06461598 2024-06-17

Signature for Precise Chemosensitivity Prediction in PDAC

365 enrolled